MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis

Journal of Gastroenterology

Volumn 40, Issue 1, 2005, Pages 16-23

  Araki, Akihiro ^a   Kanai, Takanori ^a   Ishikura, Takahiro ^a   Makita, Shin ^a   Uraushihara, Koji ^a   Iiyama, Ryoichi ^a   Totsuka, Teruji ^a   Takeda, Kiyoshi ^b   Akira, Shizuo ^b   Watanabe, Mamoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

DSS induced colitis; Inflammation; Innate immune system; Luminal bacterial flora; MyD88

Indexed keywords

CD4 ANTIGEN; CELL SURFACE MARKER; DEXTRAN SULFATE; F4 F80 ANTIGEN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; COLITIS; CONTROLLED STUDY; ENTERITIS; FECES ANALYSIS; HOST RESISTANCE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; LAMINA PROPRIA; MACROPHAGE; MONONUCLEAR CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RECTUM HEMORRHAGE; SURVIVAL RATE; T LYMPHOCYTE; WEIGHT REDUCTION; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; INTESTINAL MUCOSA; MACROPHAGES; MALE; MICE; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, IMMUNOLOGIC; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-18; RECEPTORS, INTERLEUKIN-2; SEVERITY OF ILLNESS INDEX;

EID: 20444373390     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-004-1492-9     Document Type: Article

References (47)

1. Rath HC, Schultz M, Freitag R, Dieleman LA, Li F, Linde HJ, et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun 2001;69:2277-85.
2. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002;20:495-549.
3. Sutherland L, Singleton J, Sessions J, Hanauer S, Krawitt E, Rankin G, et al. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 1991;32:1071-5.
4. Turunen UM, Farkkila MA, Hakala K, Seppälä K, Sivonen A, Ögren M, et al. Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study. Gastroenterology 1998;115:1072-8.
5. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial. Lancet 1999; 354:635-9.
6. Morrison DC, Ryan JL. Bacterial endotoxins and host immune responses. Adv Immunol 1979;28:293-450.
7. Ulevitch, RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995;13: 437-57.
8. Medzhitov R, Janeway CA. Innate immunity: The virtues of a nonclonal system of recognition. Cell 1997;91:295-8.
9. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A 1998;95:588-93.
10. Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-7.
11. Muzio M, Ni J, Feng P, Dixit VM. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997;278:1612-5.
12. Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. MyD88: An adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997;7:837-47.
13. Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL, et al. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 1998;273:12 203-9.
14. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, et al. Targeted disruption of the MyD88 gene results in loss of IL-1-, and IL-18-mediated function. Immunity 1998;9:143-50.
15. Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A. The human toll signaling pathway: Divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor- associated factor 6 (TRAF6). J Exp Med 1998;187: 2097-101.
16. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 1998;2:253-8.
17. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999;11: 115-22.
18. Takeuchi O, Takeda K, Hoshino K, Adachi O, Ogawa T, Akira S. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int Immunol 2000;12:113-7.
19. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109:1344-67.
20. Cooper HS, Murthy SNS, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-49.
21. Axelsson LG, Landstrom E, Goldschmidt TJ, Gronberg A, Bylund-Fellenius AC. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: Effects in CD4 (1)-cell depleted, athymic and NK-cell depleted SCID mice. Inflamm Res 1996;45:181-91.
22. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994; 107:1643-52.
23. Dieleman LA, Palmen MJ, Akol H, Bloemena E, PEÑA AS, Meuwissen SG, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998;114:385-91.
24. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inahgaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
25. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, et al. Targeted disruption of the MyD88 gene results in loss of IL-1-, and IL-18-mediated function. Immunity 1998;9: 143-50.
26. Takagi H, Kanai T, Okazawa A, Kishi Y, Sato T, Takaishi H, et al. Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulfate (DSS) colitis in mice. Scan J Gastroenterol 2003;33:837-44.
27. Siegmund B, Rieder F, Albrich S, Wolf K, Bidlingmaier C, Firestein GS, et al. Adenosine kinase inhibitor GP515 improves experimental colitis in mice. J Pharmacol Exp Ther 1998;296:99-105.
28. Ishikura T, Kanai T, Uraushihara K, Iiyama R, Makita S, Totuka, T, et al. IL-18 Overexpression exacerbates the development of colitis with marked infiltrates of macrophages in IL-18 transgenic mice. J Gastroenterol Hepatol 2003;18:960-9.
29. Kanai T, Totsuka T, Uraushihara K, Makita S, Nakamura T, Koganei K, et al. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J Immunol 2003;171:4156-63.
30. Atreya R, Mudter J, Finotto S, Ml̈lberg J, Jostock T, Wirtz S, et al. Blockade of interleukin 6 transsignaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn's disease and experimental colitis in vivo. Nat Med 2000;6:583-8.
31. Stallmach A, Wittig B, Giese T, Pfister K, Hoffmann JC, Bulfone-Paus S, et al. Protection of trinitrobenzene sulfonic acidinduced colitis by an interleukin-2-IgG 2b fusion protein in mice. Gastroenterology 1999;117:866-76.
32. Veltkamp C, Tonkonogy SL, De Jong YP, Albright C, Grenther WB, Balish E, et al. Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tge26 mice. Gastroenterology 2001;120:900-13.
33. Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroenterology 1984;86:174-93.
34. Duchmann R, Neurath MF, Meyer zum Buschenfelde KH. Responses to self and non-self intestinal microflora in health and inflammatory bowel disease. Res Immunol 1997;148:589-94.
35. Duchmann R, May E, Heike M, Knolle P, Neurath M, Meyer KH. T cell specificity and cross reactivity towards enterobacteria, Bacteroides, Bifidobacterium, and antigens from resident intestinal flora in humans. Gut 1999;44:812-8.
36. Macpherson A, Khoo UY, Forgacs I, Philport-Howard J, Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996;38:365-75.
37. Macpherson A, Khoo UY, Forgacs I, Philport-Howard J, Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996;38:365-75.
38. Hollander D. Permeability in Crohn's disease: Altered barrier function in healthy relatives? Gastroenterology 1993;104:1848-51.
39. Satsangi J, Jewel DP, Rosenberg WMC, Bell JI. Genetics of inflammatory bowel disease. Gut 1994;35:696-700.
40. Kitajima S, Morimoto M, Sagara E. A model for dextran sodium sulfate (DSS)-induced mouse colitis: Bacterial degradation of DSS does not occur after incubation with mouse cecal contents. Exp Anim 2002;51:203-6.
41. Kitajima S, Morimoto M, Sagara E, Shimizu C, Ikeda Y. Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Exp Anim 2001;50:387-95.
42. Cooper HS, Murphy SNS, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-49.
43. Axelsson LG, Landstrom E, Goldschmidt TJ, Gronberg A, Bylund-Fellenius AC. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: Effects in CD4(+)-cell depleted, athymic and NK-cell depleted SCID mice. Inflamm Res 1996;45:181-91.
44. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of colonic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
45. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect chronic intestinal inflammation in C.B-17 scid mice. Int Immunol 1993;5:1461-71.
46. Li M, Carpio DF, Zheng Y, Bruzzo P, Singh V, Ouaaz F, et al. An essential role of the NF-κB/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 2001;166:7128-35.
47. Kampfer H, Kalina U, Muhl H, Pfeilschifer J, Frank S. Counterregulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice. J Invest Dermatol 1999;113:369-74.